Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights (Q38234710)

31 August 2017

Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights (English)

1 reference

31 August 2017

0 references

1 reference

Dimitrios Baltzis

1

1 reference

31 August 2017

Ioanna Eleftheriadou

series ordinal

2

1 reference

31 August 2017

Aristidis Veves

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

29 July 2014

1 reference

31 August 2017

1 reference

31 August 2017

31

1 reference

31 August 2017

817-836

1 reference

31 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s12325-014-0140-x

31 August 2017

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

The pathway to foot ulceration in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

A review of the mechanisms implicated in the pathogenesis of the diabetic foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Inflammation and neuropeptides: the connection in diabetic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

The molecular biology of chronic wounds and delayed healing in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Wound healing and its impairment in the diabetic foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Mechanisms involved in the development and healing of diabetic foot ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Inflammation and wound healing: the role of the macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Cellular and molecular basis of wound healing in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Significance of endothelial progenitor cells in subjects with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Increased skin inflammation and blood vessel density in human and experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Chemokines and diabetic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Altered fibroblast proliferation and apoptosis in diabetic gingival wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Matrix metalloproteinases and epidermal wound repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Emerging drugs for the treatment of diabetic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Early changes in the skin microcirculation and muscle metabolism of the diabetic foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Microcirculation of the diabetic foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Modern aspects of cutaneous neurogenic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Off-loading the diabetic foot for ulcer prevention and healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Peripheral arterial disease and bypass surgery in the diabetic lower limb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Guidelines for the treatment of diabetic ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

A tissue-like printed material

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Tissue engineered skin substitutes created by laser-assisted bioprinting form skin-like structures in the dorsal skin fold chamber in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Innovative therapies in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

The efficacy of Apligraf in the treatment of diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Update on tissue-engineered biological dressings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Negative pressure wound therapy and other new therapies for diabetic foot ulceration: the current state of play

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Subatmospheric pressure wound therapy and the vacuum-assisted closure device: basic science and current clinical successes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Negative-pressure wound therapy induces endothelial progenitor cell mobilization in diabetic patients with foot infection or skin defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Evidence-based recommendations for the use of negative pressure wound therapy in chronic wounds: steps towards an international consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Electrical stimulation to accelerate wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

The management of neuropathic ulcers of the foot in diabetes by shock wave therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Topical administration of allogeneic mesenchymal stromal cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Differential expression of angiotensin receptors in human cutaneous wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Human skin: source of and target organ for angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Histological evaluation of the effects of angiotensin peptides on wound repair in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Acceleration of healing, reduction of fibrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Topically applied substance P enhanced healing of open excision wound in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

Specific guidelines for the treatment of diabetic foot infections 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-014-0140-X

10.1007/S12325-014-0140-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

0 references

1 reference